← Insider buys
AGIO

Agios Pharmaceuticals, Inc. · Healthcare

Chief Commercial Officer Tsveta Milanova sold $113K of Agios Pharmaceuticals, Inc.

Sold$113,224
$34.71Price
3,262Shares
−7%Stake

What AGIO did after the filing

Filed Apr 6Copier in Apr 7
The stock from Tue, Apr 7 open, $34.80
−20.3%
S&P 500, same days
+11.7%

Measured over 30 trading days, to the May 19 close.

Traded Thu, Apr 2. Filed Mon, Apr 6, 4:07 PM ET, after the close. Returns use the Apr 7 open and the May 19 close. Not investment advice.